Bioinformatics Laboratories Protein Production RNA 
Drug Discovery World
NOVEMBER 13, 2023
Novel/alternative ML-enabled screening technologies for higher POS Following chairperson’s remarks from M Frank Erasmus, PhD, Head, Bioinformatics, Specifica, there will be four presentations and a panel discussion. These topics include: High-throughput (HTP) protein production and AI and automation in bioprocess development.
Drug Discovery World
NOVEMBER 30, 2023
It was presented by Xiaole Shirley Liu, PhD, CEO, GV20 Therapeutics, and titled: ‘AI-based target and antibody discovery from patient tumour profiles’. To demonstrate the utility of the company’s SYNTAX system in gene assembly, the 1.7 kb Influenza A hemagglutinin gene was used as a model system.
Expert insights. Personalized for you.
147 
Let's personalize your content